Anders Bjartell
Anders Bjartell
Professor i Urologi
Verified email at
Cited by
Cited by
Apalutamide for metastatic, castration-sensitive prostate cancer
KN Chi, N Agarwal, A Bjartell, BH Chung, AJ Pereira de Santana Gomes, ...
New England Journal of Medicine 381 (1), 13-24, 2019
Active surveillance for low-risk prostate cancer worldwide: the PRIAS study
M Bul, X Zhu, R Valdagni, T Pickles, Y Kakehi, A Rannikko, A Bjartell, ...
European urology 63 (4), 597-603, 2013
MicroRNA in prostate, bladder, and kidney cancer: a systematic review
JWF Catto, A Alcaraz, AS Bjartell, RDV White, CP Evans, S Fussel, ...
European urology 59 (5), 671-681, 2011
Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial
E Haglind, S Carlsson, J Stranne, A Wallerstedt, U Wilderäng, ...
European urology 68 (2), 216-225, 2015
ETS gene fusions in prostate cancer: from discovery to daily clinical practice
SA Tomlins, A Bjartell, AM Chinnaiyan, G Jenster, RK Nam, MA Rubin, ...
European urology 56 (2), 275-286, 2009
Enzalutamide in men with chemotherapy-naive metastatic castration-resistant prostate cancer: extended analysis of the phase 3 PREVAIL study
TM Beer, AJ Armstrong, D Rathkopf, Y Loriot, CN Sternberg, CS Higano, ...
European urology 71 (2), 151-154, 2017
The role of SPINK1 in ETS rearrangement-negative prostate cancers
SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ...
Cancer cell 13 (6), 519-528, 2008
Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019
S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ...
European urology 77 (4), 508-547, 2020
The contemporary concept of significant versus insignificant prostate cancer
G Ploussard, JI Epstein, R Montironi, PR Carroll, M Wirth, MO Grimm, ...
European urology 60 (2), 291-303, 2011
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
AJ Vickers, D Ulmert, DD Sjoberg, CJ Bennette, T Björk, A Gerdtsson, ...
Bmj 346, 2013
Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth
B Wegiel, D Gallo, E Csizmadia, C Harris, J Belcher, GM Vercellotti, ...
Cancer research 73 (23), 7009-7021, 2013
Advances in magnetic resonance imaging: how they are changing the management of prostate cancer
A Sciarra, J Barentsz, A Bjartell, J Eastham, H Hricak, V Panebianco, ...
European urology 59 (6), 962-977, 2011
Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells
P Östling, SK Leivonen, A Aakula, P Kohonen, R Mäkelä, Z Hagman, ...
Cancer research 71 (5), 1956-1967, 2011
Apalutamide in patients with metastatic castration-sensitive prostate cancer: final survival analysis of the randomized, double-blind, phase III TITAN study
KN Chi, S Chowdhury, A Bjartell, BH Chung, ...
Journal of Clinical Oncology 39 (20), 2294-2303, 2021
The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to …
J Malm, O Sørensen, T Persson, M Frohm-Nilsson, B Johansson, ...
Infection and immunity 68 (7), 4297-4302, 2000
The mutational landscape of prostate cancer
CE Barbieri, CH Bangma, A Bjartell, JWF Catto, Z Culig, H Grönberg, ...
European urology 64 (4), 567-576, 2013
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study
AJ Vickers, AM Cronin, T Björk, J Manjer, PM Nilsson, A Dahlin, A Bjartell, ...
Bmj 341, 2010
Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences
O Yossepowitch, A Bjartell, JA Eastham, M Graefen, BD Guillonneau, ...
European urology 55 (1), 87-99, 2009
SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas
K Magnusson, M De Wit, DJ Brennan, LB Johnson, SF McGee, ...
The American journal of surgical pathology 35 (7), 937-948, 2011
Epigenetics in prostate cancer: biologic and clinical relevance
C Jerónimo, PJ Bastian, A Bjartell, GM Carbone, JWF Catto, SJ Clark, ...
European urology 60 (4), 753-766, 2011
The system can't perform the operation now. Try again later.
Articles 1–20